ClinicalTrials HQ

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

Recruiting · NCT05125016 · Registry updated 2026-05-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerMetastatic Castration-resistant Prostate CancerRecruitingPhase 1 / Phase 22026-05-05NCT05125016

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Regeneron Pharmaceuticals238

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atrium Health Levine Cancer InstituteCharlotteUnited States14
Fox Chase Cancer CenterPhiladelphiaUnited States259
MD Anderson Cancer CenterHoustonUnited States589
Medical College of WisconsinMilwaukeeUnited States483
Norton Cancer InstituteLouisvilleUnited States37
Penn Medicine University of Pennsylvania Health SystemPhiladelphiaUnited States1
Roswell Park Cancer InstituteBuffaloUnited States382
Rutgers Cancer Institute of New JerseyNew BrunswickUnited States67
Stanford University Medical Center - Blake Wilbur DrivePalo AltoUnited States1
The Ohio State University James Cancer HospitalColumbusUnited States2
Thomas Jefferson University HospitalPhiladelphiaUnited States271
University of Maryland Greenebaum Cancer CenterBaltimoreUnited States20
Yale University HospitalNew HavenUnited States3